Ganeden is at the forefront of probiotic research and product development. Ganeden technology can be found in cutting edge products in areas as diverse as probiotic functional foods and beverages, sports nutrition products, cosmetic applications and animal health products. Ganeden has completed dozens of scientific trials (over 20 of them published in peer reviewed journals), demonstrating the safety and efficacy of its probiotic strain, GanedenBC30, and earned FDA GRAS status in 2012. Ganeden has also conducted significant research on the performance of its cosmeceutical ingredient, Bonicel. In addition to its extensive library of research, Ganeden continues to invest significant resources in science supporting its ingredients and its technologies.Ganeden maintains an extensive intellectual property portfolio with patent and trademark protection for an array of technologies all over the world. This means products developed in partnership with Ganeden enjoy a unique, protected position in the marketplace.In 2011 Ganeden's consumer brands Digestive Advantage and Sustenex were acquired by Schiff Nutrition-TPG ( now owned by Reckitt Benckiser) for more than 2x revenue ($40 million). To date Ganeden has sold well over 7 billion doses of its signature probiotic ingredient GanedenBC30 through its OTC brands and partners. As of 2015 sales of Ganeden's partner products alone at retail have increased to $1 billion over the last 8 years.